Real-time measurement of anti-HBs level and donor-specific transfusion via portal vein may reduce amount of HBIG after living related liver transplantation [3]

American Journal of Gastroenterology

Volumn 97, Issue 2, 2002, Pages 488-489

  Sato, Yoshinobu ^a,b   Ichida, Takafumi ^a   Hatakeyama, Katsuyoshi ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; LAMIVUDINE; TACROLIMUS;

ANTIBODY TITER; DRUG COST; DRUG MEGADOSE; HEPATITIS B; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONOR; MEASUREMENT; PORTAL VEIN; PRIORITY JOURNAL; RECURRENT DISEASE; STEROID THERAPY; TRANSFUSION; VACCINATION;

EID: 0036181873     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.05504.x     Document Type: Letter

References (8)

1. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation
2. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin
3. Long-term results of liver transplantation in HbsAg-positive patients recieving anti-HbsAg passive immunoprophylaxis
4. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: A new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation
5. Role of CD56+CD3+ cells in the graft in living related partial liver transplantation
6. Macrochimerism of donor type CD56+CD3+ T cells in donor specific transfusion via portal vein following living related donor liver transplantation
7. Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
8. Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin